Pharma

25 companies tracked

NEUTRAL28NEUTRAL

Signals 7d

Companies

↓0%

Signal Trend

WHO monitoring shows 2 outbreak signals below alert threshold. No supply chain disruptions flagged. Pharma signals are stable.

Industries›Pharma

🏆 Sector Rankings →🏢 All Companies →

Countries

Opportunities

Country posture computes once companies have scores

Risks

Country posture computes once companies have scores

Sort by

Companies

Opportunities(10)See all →

AZNAstraZeneca PLC🇬🇧↓0%EARLY LLYEli Lilly and Company🇺🇸↓0%EARLY AMGNAmgen Inc.🇺🇸↓0%EARLY RHHBYRoche Holding AG🇨🇭↓0%EARLY DSNKYDaiichi Sankyo Company, Limited🇯🇵↓0%EARLY CSLLYCSL Limited🇦🇺↓0%EARLY GILDGilead Sciences Inc.🇺🇸↓0%EARLY NVSNovartis AG🇨🇭↓0%EARLY ABBVAbbVie Inc.🇺🇸↓0%EARLY SNYSanofi🇫🇷↓0%EARLY

Risks(4)See all →

REGNRegeneron Pharmaceuticals Inc.🇺🇸↓0%AVOID MRKMerck & Co. Inc.🇺🇸↓0%AVOID BAYRYBayer AG🇩🇪↓0%AVOID BMYBristol-Myers Squibb Company🇺🇸↓0%AVOID

Investment Themes

💊Pharma Supply Chain ReshoringOPP

Investment Thesis

WHO monitoring shows 2 outbreak signals below alert threshold. No supply chain disruptions flagged. Pharma signals are stable.

Market Pricing Analysis

Market gap+1%

Signal trend (7d)↓ 0% vs 7d avg

Recommended actionNEUTRAL

Score Breakdown — 28 / 100

Signal trend (direction + momentum)5 / 30

Market pricing gap5 / 25

Source quality + recency12 / 25

Macro / sector tailwind6 / 20

Total28 / 100

Key Risk Factors

⚠Drug pricing reform risk in US election cycle

⚠GLP-1 supply chain capacity constraints building

Business Context

Supply chain exposure

No country signal data

Labor risk

0 political signals in past 7d

Regulatory environment

Normal

Diplomatic Relevance

Strategic classification

Pharmaceuticals

Key countries in signal set

No country signal data

Sanction exposure

No flagged exposure